Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB, Breedveld FC, van Laar JM. Verburg RJ, et al. Among authors: barge rm. Arthritis Rheum. 2001 Apr;44(4):754-60. doi: 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N. Arthritis Rheum. 2001. PMID: 11315914 Free article. Clinical Trial.
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
van Oosterhout M, Verburg RJ, Levarht EW, Moolenburgh JD, Barge RM, Fibbe WE, van Laar JM. van Oosterhout M, et al. Among authors: barge rm. Ann Rheum Dis. 2005 Dec;64(12):1783-5. doi: 10.1136/ard.2004.034793. Ann Rheum Dis. 2005. PMID: 16284342 Free PMC article.
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.
Barge RM, Osanto S, Marijt WA, Starrenburg CW, Fibbe WE, Nortier JW, Falkenburg JH, Willemze R. Barge RM, et al. Exp Hematol. 2003 Oct;31(10):865-72. doi: 10.1016/s0301-472x(03)00200-5. Exp Hematol. 2003. PMID: 14550801 Free article.
Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH. Posthuma EF, et al. Among authors: barge rm. Biol Blood Marrow Transplant. 2004 Mar;10(3):204-12. doi: 10.1016/j.bbmt.2003.11.003. Biol Blood Marrow Transplant. 2004. PMID: 14993886 Free article.
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N, Toit C, Abrahams L, Thomas V, Bunjes D, Duncker C, Wiesneth M, Selleslag D, Hidajat M, Starobinski M, Bird P, Waldmann H. Hale G, et al. Bone Marrow Transplant. 2000 Jul;26(1):69-76. doi: 10.1038/sj.bmt.1702477. Bone Marrow Transplant. 2000. PMID: 10918407
Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.
Pawson R, Dyer MJ, Barge R, Matutes E, Thornton PD, Emmett E, Kluin-Nelemans JC, Fibbe WE, Willemze R, Catovsky D. Pawson R, et al. J Clin Oncol. 1997 Jul;15(7):2667-72. doi: 10.1200/JCO.1997.15.7.2667. J Clin Oncol. 1997. PMID: 9215839 Clinical Trial.
Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
van Kempen-Harteveld ML, Brand R, Kal HB, Verdonck LF, Hofman P, Schattenberg AV, van der Maazen RW, Cornelissen JJ, Eijkenboom WM, van der Lelie JP, Oldenburger F, Barge RM, van Biezen A, Vossen JM, Noordijk EM, Struikmans H. van Kempen-Harteveld ML, et al. Among authors: barge rm. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1444-54. doi: 10.1016/j.ijrobp.2007.11.072. Epub 2008 Mar 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18294781
61 results